BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19919870)

  • 1. Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans.
    Bordicchia M; Battistoni I; Mancinelli L; Giannini E; Refi G; Minardi D; Muzzonigro G; Mazzucchelli R; Montironi R; Piscitelli F; Petrosino S; Dessì-Fulgheri P; Rappelli A; Di Marzo V; Sarzani R
    Metabolism; 2010 May; 59(5):734-41. PubMed ID: 19919870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients.
    Sarzani R; Bordicchia M; Marcucci P; Bedetta S; Santini S; Giovagnoli A; Scappini L; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Rappelli A
    Metabolism; 2009 Mar; 58(3):361-7. PubMed ID: 19217452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state.
    Nannipieri M; Bonotti A; Anselmino M; Cecchetti F; Madec S; Mancini E; Baldi S; Santini F; Pinchera A; Rossi M; Ferrannini E
    Int J Obes (Lond); 2007 Dec; 31(12):1843-8. PubMed ID: 17607322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
    Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
    Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese.
    Bennetzen MF; Nielsen TS; Paulsen SK; Bendix J; Fisker S; Jessen N; Lund S; Richelsen B; Pedersen SB
    Eur J Clin Invest; 2010 Feb; 40(2):121-6. PubMed ID: 20039929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity.
    Kempf K; Hector J; Strate T; Schwarzloh B; Rose B; Herder C; Martin S; Algenstaedt P
    Horm Metab Res; 2007 Aug; 39(8):596-600. PubMed ID: 17712725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot.
    Walker GE; Verti B; Marzullo P; Savia G; Mencarelli M; Zurleni F; Liuzzi A; Di Blasio AM
    Obesity (Silver Spring); 2007 Aug; 15(8):1933-43. PubMed ID: 17712110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women.
    Goedecke JH; Wake DJ; Levitt NS; Lambert EV; Collins MR; Morton NM; Andrew R; Seckl JR; Walker BR
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):81-7. PubMed ID: 16817824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue.
    Sarzani R; Bordicchia M; Marcucci P; Minardi D; Muzzonigro G; Dessì-Fulgheri P; Rappelli A
    J Hum Hypertens; 2010 Mar; 24(3):213-9. PubMed ID: 19536167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK; Pedersen SB; Fisker S; Richelsen B
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of the rs1049353 polymorphism of the CNR1 gene with hypoadiponectinemia.
    Dinu IR; Popa SG; Moţa M; Moţa E; Stănciulescu C; Ioana M; Cruce M
    Rom J Morphol Embryol; 2011; 52(3):791-5. PubMed ID: 21892520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth weight and gender determine expression of adipogenic, lipogenic and adipokine genes in perirenal adipose tissue in the young adult sheep.
    Muhlhausler BS; Ritorto V; Schultz C; Chatterton BE; Duffield JA; McMillen IC
    Domest Anim Endocrinol; 2008 Jul; 35(1):46-57. PubMed ID: 18308504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.
    Smith SR; Lovejoy JC; Greenway F; Ryan D; deJonge L; de la Bretonne J; Volafova J; Bray GA
    Metabolism; 2001 Apr; 50(4):425-35. PubMed ID: 11288037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms.
    Engl J; Sturm W; Sandhofer A; Kaser S; Tschoner A; Tatarczyk T; Weiss H; Tilg H; Patsch JR; Ebenbichler CF
    Eur J Clin Invest; 2008 Apr; 38(4):238-44. PubMed ID: 18312420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus.
    Catalán V; Gómez-Ambrosi J; Rotellar F; Silva C; Gil MJ; Rodríguez A; Cienfuegos JA; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):598-601. PubMed ID: 17371481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expression and function of the endocannabinoid system in human epicardial adipose tissue in relation to heart disease.
    Cappellano G; Uberti F; Caimmi PP; Pietronave S; Mary DA; Dianzani C; Micalizzi E; Melensi M; Boldorini R; Nicosia G; Crosio E; Chiocchetti A; Aina F; Prat M; Dianzani U; Vacca G; Ariatti C; Grossini E
    Can J Cardiol; 2013 Apr; 29(4):499-509. PubMed ID: 22926037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss.
    Bennetzen MF; Wellner N; Ahmed SS; Ahmed SM; Diep TA; Hansen HS; Richelsen B; Pedersen SB
    Int J Obes (Lond); 2011 Nov; 35(11):1377-84. PubMed ID: 21326208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
    Kunos G
    Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.